UnitedHealth Group, US91324P1021

UnitedHealth raises 2026 outlook and UnitedHealth Group stock trades at EUR 337.30

Published on 10/14/2026 at 09:59 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Adjusted earnings reached USD 4.69 versus USD 4.14 consensus. UnitedHealth Group stock costs EUR 337.30 on October 14, 2026 versus Xetra close EUR 337.40.

Earnings and analyst signals

  • UnitedHealth raised its adjusted 2026 earnings outlook to at least USD 20.50 per share on October 13, 2026.
  • Mizuho analyst Ann Hynes reiterated an Outperform rating and a USD 493.00 target on October 13, 2026.
  • UnitedHealth Group stock trades at EUR 337.30 at 9:46 a.m. CEST on October 14, 2026, 0.03 percent below the Xetra close of October 13, 2026.
Architekturaufnahme eines symmetrischen Unternehmensgebäudes mit Herbstbäumen und Spiegelteich
UnitedHealth Group US91324P1021 repräsentiert durch generischen Corporate Campus mit Herbstbäumen in Minnesota, Illustration mit AI erstellt.

UnitedHealth Group (ISIN US91324P1021) was trading at EUR 337.30 at Lang & Schwarz on October 14, 2026 at 9:46 a.m. CEST, 0.03 percent below the Xetra close of October 13, 2026 at EUR 337.40. On October 13, 2026, UnitedHealth Group reported third-quarter revenue of USD 112.70 billion and raised its full-year adjusted earnings outlook to at least USD 20.50 per share.

Third-quarter profit resets outlook

The company reported adjusted earnings of USD 4.69 per share for the third quarter of 2026, while GAAP earnings reached USD 4.56 per share. Earnings from operations were USD 6.56 billion, and operating cash flow was USD 5.12 billion in the same quarter.

CNBC reported that adjusted earnings exceeded the USD 4.14 consensus estimate, while revenue topped the USD 111.40 billion expectation. Revenue still declined from USD 113.16 billion in the third quarter of 2025, making the earnings improvement more important than the top-line result.

Three dates that changed the setup

On October 12, 2026, TD Cowen maintained a Hold rating and cut its target from USD 430.00 to USD 402.00, according to Yahoo Finance. On October 13, 2026, Mizuho analyst Ann Hynes reiterated Outperform and set a USD 493.00 target, as reported by Markets Insider.

What does margin recovery mean?

The third-quarter medical care ratio was 88.40 percent, down from 89.90 percent a year earlier. Healthcare Dive reported that UnitedHealthcare generated USD 2.80 billion in operating profit, USD 1.00 billion more than a year earlier, while Optum Health produced USD 735.00 million against USD 41.00 million.

Next reporting date

The next earnings report is scheduled for January 20, 2027, according to Investing.com. The date puts the next major test on the company's ability to convert lower medical costs into durable earnings growth.

Stock stays near Xetra base

At Lang & Schwarz, UnitedHealth Group stock was trading at EUR 337.30 on October 14, 2026 at 9:46 a.m. CEST, 0.03 percent below the Xetra close of October 13, 2026 at EUR 337.40. The primary listing is on the NYSE, where the latest USD quote was USD 377.76 at 4:00 p.m. ET on October 13, 2026, while the market capitalization was USD 343.1 billion.

The further course of trading is shown by the continuously updated real-time quote of UnitedHealth Group stock.

UnitedHealth Group stock at a glance

  • Company: UnitedHealth Group Incorporated
  • ISIN: US91324P1021
  • Ticker: UNH
  • Primary exchange: NYSE
  • Price Lang & Schwarz as of October 14, 2026, 9:46 a.m. CEST: EUR 337.30
  • Change versus Xetra close: minus 0.03 percent versus the Xetra close of October 13, 2026
  • Xetra close October 13, 2026: EUR 337.40
  • Market capitalization: USD 343.1 billion as of October 13, 2026
  • 52-week range: USD 255.97-461.62 as of October 13, 2026
  • Sector / Industry: Healthcare / Medical - Healthcare Plans

Market context: Market report S&P 500.

More news and analyses on UnitedHealth Group stock

Disclaimer...

en | US91324P1021 | UNITEDHEALTH GROUP | boerse | 70322163 | bgmi